Clinical value of severity markers in acute pancreatitis

Scandinavian Journal of Surgery

Volumn 94, Issue 2, 2005, Pages 118-123

  Lempinen, Marko ^a   Puolakkainen, P ^a   Kemppainen, E ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Acute pancreatitis; Disease severity; Severity markers

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; PHOSPHOLIPASE A2; PROCALCITONIN; TRYPSIN; TRYPSINOGEN ACTIVATION PEPTIDE;

ACUTE PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE SEVERITY; GLASGOW OUTCOME SCALE; HIGH RISK PATIENT; HUMAN; PARAMETER; PROGNOSIS; REVIEW;

EID: 23844527244     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690509400207     Document Type: Review

References (64)

1. Beger HG, Rau B, Isenmann R: Prevention of severe change in acute pancreatitis: prediction and prevention. J Hepatobiliary Pancreat Surg 2001;8:140-147
2. Beger HG, Isenmann R: Surgical management of necrotizing pancreatitis. Surg Clin North Am 1999;79:783-800, ix
3. Isenmann R, Rau B, Beger HG: Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas 2001;22:274-278
4. Tsiotos GG, Luque-de Leon E, Soreide JA, Bannon MP, Zietlow SP, Baerga-Varela Y, Sarr M: Management of necrotizing pancreatitis by repeated operative necrosectomy using a zipper technique. Am J Surg 1998;175:91-98
5. Steinberg W, Tenner S: Acute pancreatitis. N Engl J Med 1994; 330:1198-1210
6. Steer ML: Frank Brooks memorial lecture: The early intraacinar cell events which occur during acute pancreatitis. Pancreas 1998;17:31-37
7. Hietaranta AJ, Saluja AK, Bhagat L, Singh VP, Song AM, Steer ML: Relationship between NF-kappaB and trypsinogen activation in rat pancreas after supramaximal caerulein stimulation. Biochem Biophys Res Commun 2001;280:388-395
8. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK Jr, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-145
9. McKay CJ, Evans S, Sinclair M, Carter CR, Imrie CW: High early mortality rate from acute pancreatitis in Scotland, 1984-1995. Br J Surg 1999;86:1302-1305
10. Rinderknecht H: Genetic determinants of mortality in acute necrotizing pancreatitis. Int J Pancreatol 1994;16:11-15
11. Halonen KI, Leppäniemi AK, Puolakkainen PA, Lundin JE, Kemppainen EA, Hietaranta AJ, Haapiainen RK: Severe acute pancreatitis: prognostic factors in 270 consecutive patients. Pancreas 2000;21:266-271
12. Brivet FG, Emilie D, Galanaud P: Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med 1999;27: 749-755
13. Bassi C, Larvin M, Villatoro E: Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev 2003:CD002941
14. Sharma VK, Howden CW: Metaanalysis of randomized controlled trials of endoscopic retrograde cholangiography and endoscopic sphincterotomy for the treatment of acute biliary pancreatitis. Am J Gastroenterol 1999;94:3211-3214
15. Dervenis CG: Staging acute pancreatitis: where are we now? Pancreatology 2001;1:201-206
16. Lankisch PG, Schirren CA, Kunze E: Undetected fatal acute pancreatitis: why is the disease so frequently overlooked? Am J Gastroenterol 1991;86:322-326
17. Appelros S, Borgström A: Incidence, aetiology and mortality rate of acute pancreatitis over 10 years in a defined urban population in Sweden. Br J Surg 1999;86:465-470
18. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC: Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974;139:69-81
19. Imrie CW, Benjamin IS, Ferguson JC, McKay AJ, Mackenzie I, O'Neill J, Blumgart LH: A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 1978; 65:337-341
20. Osborne DH, Imrie CW, Carter DC: Biliary surgery in the same admission for gallstone-associated acute pancreatitis. Br J Surg 1981;68:758-761
21. Toh SK, Phillips S, Johnson CD: A prospective audit against national standards of the presentation and management of acute pancreatitis in the South of England. Gut 2000;46:239-243
22. Merkle EM, Görich J: Imaging of acute pancreatitis. Eur Radiol 2002;12:1979-1992
23. Balthazar EJ: Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology 2002;223:603-613
24. Lecesne R, Taourel P, Bret PM, Atri M, Reinhold C: Acute pancreatitis: interobserver agreement and correlation of CT and MR cholangiopancreatography with outcome. Radiology 1999;211:727-735
25. Pepys MB: C-reactive protein fifty years on. Lancet 1981;1:653-657
26. Puolakkainen P, Valtonen V, Paananen A, Schröder T: C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut 1987;28:764-771
27. Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, Beger HG, Hietaranta AJ, Puolakkainen PA: Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000;355:1955-1960
28. Lempinen M, Kylänpää-Bäck ML, Stenman UH, Puolakkainen P, Haapiainen R, Finne P, Korvuo A, Kemppainen E: Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine. Clin Chem 2001;47:2103-2107
29. Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, Modlin I: Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol 1999;25:195-210
30. Pezzilli R, Billi P, Miniero R, Fiocchi M, Cappelletti O, Morselli-Labate AM, Barakat B, Sprovieri G, Miglioli M: Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C- reactive protein. Dig Dis Sci 1995;40:2341-2348
31. Chen CC, Wang SS, Lee FY, Chang FY, Lee SD: Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol 1999;94:213-218
32. Messmann H, Vogt W, Holstege A, Lock G, Heinisch A, von Fürstenberg A, Leser HG, Zirngibl H, Schölmerich J: Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut 1997;40:80-85
33. Gross V, Andreesen R, Leser HG, Ceska M, Liehl E, Lausen M, Farthmann EH, Schölmerich J: Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992,22:200-203
34. Mentula P, Kylänpää ML, Kemppainen E, Jansson SE, Sarna S, Puolakkainen P, Haapiainen R, Repo H: Early prediction of organ failure by combined markers in patients with acute pancreatitis. Br J Surg 2005;92:68-75
35. McKay C, Imrie CW, Baxter JN: Mononuclear phagocyte activation and acute pancreatitis. Scand J Gastroenterol Suppl 1996;219:32-36
36. Beutler B, Cerami A: Cachectin: more than a tumor necrosis factor. N Engl J Med 1987;316:379-385
37. Paajanen H, Laato M, Jaakkola M, Pulkki K, Niinikoski J, Nordback I: Serum tumour necrosis factor compared with C-reactive protein in the early assessment of severity of acute pancreatitis. Br J Surg 1995;82:271-273
38. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-518
39. Hensel M, Volk T, Docke WD, Kern F, Tschirna D, Egerer K, Konertz W, Kox WJ: Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1998;89:93-104
40. Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG: The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997;41:832-840
41. Müller CA, Uhl W, Printzen G, Gloor B, Bischofberger H, Tcholakov O, Bühler MW: Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis. Gut 2000;46:233-238
42. Kylänpää-Bäck ML, Takala A, Kemppainen EA, Puolakkainen PA, Leppäniemi AK, Karonen SL, Orpana A, Haapiainen RK, Repo H: Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 2001;29:63-69.
43. Kylänpää-Bäck ML, Takala A, Kemppainen E, Puolakkainen P, Haapiainen R, Repo H: Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg 2001;88:222-227
44. Wereszczynska S, Dabrowski A, Jedynak M, Gabryelewicz A: Oxidative stress as an early prognostic factor in acute pancreatitis (AP): its correlation with serum phospholipase A2 (PLA2) and plasma polymorphonuclear elastase (PMN-E) in different-severity forms of human AP. Pancreas 1998;17:163-168
45. Dominguez-Munoz JE, Carballo F, Garcia MJ, de Diego JM, Rabago L, Simon MA, de la Morena J: Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicentre study. Br J Surg 1991; 78:1230-1234
46. Mayer JM, Raraty M, Slavin J, Kemppainen E, Fitzpatrick J, Hietaranta A, Puolakkainen P, Beger HG, Neoptolemos JP: Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg 2002;89:163-171
47. Pezzilli R, Melzi d'Eril GV, Morselli-Labate AM, Merlini G, Barakat B, Bosoni T: Serum amyloid A, procalcitonin, and C-reactive protein in early assessment of severity of acute pancreatitis. Dig Dis Sci 2000;45:1072-1078
48. Rau B, Steinbach G, Baumgart K, Gansauge F, Grünert A, Beger HG: Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant. Crit Care Med 2000;28:736-742
49. Hedström J, Leinonen J, Sainio V, Stenman UH: Time-resolved immunofluorometric assay of trypsin-2 complexed with alpha 1-antitrypsin in serum. Clin Chem 1994;40:1761-1765
50. Lempinen M, Stenman UH, Finne P, Puolakkainen P, Haapiainen R, Kemppainen E: Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis. J Surg Res 2003;111:267-273
51. Hedström J, Sainio V, Kemppainen E, Haapiainen R, Kivilaakso E, Schröder T, Leinonen J, Stenman UH: Serum complex of trypsin 2 and alpha 1 antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients. BMJ 1996;313:333-337
52. Pezzilli R, Billi P, Plate L, Barakat B, Bongiovanni F, Miglioli M: Human pancreatic secretory trypsin inhibitor in the assessment of the severity of acute pancreatitis. A comparison with C-reactive protein. J Clin Gastroenterol 1994;19:112-117
53. Lempinen M, Stenman UH, Puolakkainen P, Hietaranta A, Haapiainen R, Kemppainen E: Sequential changes in pancreatic markers in acute pancreatitis. Scand J Gastroenterol 2003;38:666-675
54. Grönroos JM, Nevalainen TJ: Increased concentrations of synovial-type phospholipase A2 in serum and pulmonary and renal complications in acute pancreatitis. Digestion 1992;52:232-236
55. Mayer J, Rau B, Grewe M, Schoenberg MH, Nevalainen TJ, Beger HG: Secretory phospholipase A2 in patients with infected pancreatic necroses in acute pancreatitis. Pancreas 1998;17:272-277
56. Hietaranta A, Kemppainen E, Puolakkainen P, Sainio V, Haapiainen R, Peuravuori H, Kivilaakso E, Nevalainen T: Extracellular phospholipases A2 in relation to systemic inflammatory response syndrome (SIRS) and systemic complications in severe acute pancreatitis. Pancreas 1999;18:385-391
57. Gudgeon AM, Heath DI, Hurley P, Jehanli A, Patel G, Wilson C, Shenkin A, Austen BM, Imrie CW, Hermon-Taylor J: Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990;335:4-8
58. Johnson CD, Lempinen M, Imrie CW, Puolakkainen P, Kemppainen E, Carter R, McKay C: Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis. Br J Surg 2004;91:1027-1033
59. Kemppainen E, Mayer J, Puolakkainen P, Raraty M, Slavin J, Neoptolemos JP: Plasma trypsinogen activation peptide in patients with acute pancreatitis. Br J Surg 2001;88:679-680
60. Heath DI, Cruickshank A, Gudgeon AM, Jehanli A, Shenkin A, Imrie CW: The relationship between pancreatic enzyme release and activation and the acute-phase protein response in patients with acute pancreatitis. Pancreas 1995;10:347-353
61. Mayer JM, Raraty M, Slavin J, Kemppainen E, Fitzpatrick J, Hietaranta A, Puolakkainen P, Beger HG, Neoptolemos JP: Severe acute pancreatitis is related to increased early urinary levels of the activation Peptide of pancreatic phospholipase A(2). Pancreatology. 2002;2:535-542
62. Saez J, Martinez J, Trigo C, Sanchez-Paya J, Grino P, Company L, Laveda R, Penalva JC, Garcia C, Perez-Mateo M: A comparative study of the activation peptide of carboxypeptidase B and trypsinogen as early predictors of the severity of acute pancreatitis. Pancreas 2004;29:e9-14
63. Appelros S, Thim L, Borgström A: Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis. Gut 1998;42:97-102
64. Appelros S, Petersson U, Toh S, Johnson C, Borgström A: Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis. Br J Surg 2001;88:216-221